Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD. | Ann Hematol | 2023 | 37817009 | PubTator, text mining | PubMed |
| Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis. | Front Med (Lausanne) | 2023 | 37809329 | PubTator, text mining | PubMed |
| Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches. | Open Life Sci | 2023 | 37808875 | PubTator, text mining | PubMed |
| Case report: Autoimmune hemolytic anemia caused by warm and cold autoantibodies with complement activation-etiological and therapeutic issues. | Front Pediatr | 2023 | 37794962 | PubTator, text mining | PubMed |
| Plasma proteomic associations with genetics and health in the UK Biobank. | Nature | 2023 | 37794186 | PubTator, text mining | PubMed |
| Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels. | Front Immunol | 2023 | 37771595 | PubTator, text mining | PubMed |
| Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2023 | 37771589 | PubTator, text mining | PubMed |
| Comparative Proteomic Analysis of Exosomes Derived from Patients Infected with Non-Tuberculous Mycobacterium and Mycobacterium tuberculosis. | Microorganisms | 2023 | 37764178 | PubTator, text mining | PubMed |
| Complement System Proteins in the Human Aqueous Humor and Their Association with Primary Open-Angle Glaucoma. | J Pers Med | 2023 | 37763167 | PubTator, text mining | PubMed |
| Immunological Biomarkers as Predictors of Treatment Response in Psychotic Disorders. | J Pers Med | 2023 | 37763150 | PubTator, text mining | PubMed |
| Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | 37762312 | PubTator, text mining | PubMed |
| Slowly Making Sense: A Review of the Two-Step Venom System within Slow (Nycticebus spp.) and Pygmy Lorises (Xanthonycticebus spp.). | Toxins (Basel) | 2023 | 37755940 | PubTator, text mining | PubMed |
| Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants. | Antibodies (Basel) | 2023 | 37753968 | PubTator, text mining | PubMed |
| Structural biology of complement receptors. | Front Immunol | 2023 | 37753090 | PubTator, text mining | PubMed |
| Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy. | Drugs | 2023 | 37747686 | PubTator, text mining | PubMed |
| NETosis: an emerging therapeutic target in renal diseases. | Front Immunol | 2023 | 37744367 | PubTator, text mining | PubMed |
| Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection. | PeerJ | 2023 | 37744234 | PubTator, text mining | PubMed |
| Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response. | Clin Proteomics | 2023 | 37735622 | PubTator, text mining | PubMed |
| Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies. | J Exp Clin Cancer Res | 2023 | 37735434 | PubTator, text mining | PubMed |
| Patients on the Transplant Waiting List Have Anti-Swine Leukocyte Antigen Class I Antibodies. | Immunohorizons | 2023 | 37712913 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers?page=10